Familial paraganglioma syndrome: Applying genetic screening in otolaryngology

Journal of Otolaryngology - Head and Neck Surgery

Volumn 39, Issue 6, 2010, Pages 646-653

  Dziegielewski, Peter T ^a   Knox, Aaron ^b   Liu, Richard ^a   Hung, Ryan W ^b   Harris, Jeffrey ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Familial paraganglioma syndrome; Genetic screening; Paraganglioma

Indexed keywords

ADULT; ALGORITHM; CASE REPORT; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC SCREENING; HEAD AND NECK TUMOR; HUMAN; MALE; MORBIDITY; OTORHINOLARYNGOLOGY; PARAGANGLIOMA; PRIORITY JOURNAL; REVIEW;

ADULT; ALGORITHMS; COST-BENEFIT ANALYSIS; FEMALE; GENETIC TESTING; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUTATION; PARAGANGLIOMA; RETROSPECTIVE STUDIES; SUCCINATE DEHYDROGENASE;

EID: 78650212228     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2010.090322     Document Type: Review

References (23)

1. Martin TP, Irving RM, Maher ER. The genetics of paragangliomas: a review. Clin Otolaryngol 2007;32:7-11.
2. Timmers HJ, Gimenez-Roqueplo AP, Mannelli M, et al. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocr Relat Cancer 2009;16:391-400.
3. Neumann HP, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943-51.
4. Schiavi F, Savvoukidis T, Trabalzini F, et al. Paraganglioma syndrome: SDHB, SDHC, and SDHD mutations in head and neck paragangliomas. Ann N Y Acad Sci 2006;1073:190-7.
5. Baysal BE, Willett-Brozick JE, Lawrence EC, et al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 2002;39:178-83.
6. Drovdlic CM, Myers EN, Peters JA, et al. Proportion of heritable paraganglioma cases and associated clinical characteristics. Laryngoscope 2001;111:1822-7.
7. Karaman E, Isildak H, Yilmaz M, et al. Management of paragangliomas in otolaryngology practice: review of a 7-year experience. J Craniofac Surg 2009;20:1294-7.
8. Biron VL, Waghray R, Medlicott SA, et al. Inflammatory pseudotumours of the larynx: three cases and a review of the literature. J Otolaryngol Head Neck Surg 2008;37:E32-8.
9. Chau JK, Girgis S, Chau JK, et al. Laryngeal collision tumour: pleomorphic adenoma and squamous cell carcinoma. J Otolaryngol Head Neck Surg 2009;38:E31-4.
10. Peczkowska M, Cascon A, Prejbisz A, et al. Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation. Nat Clin Pract Endocrinol Metab 2008;4:111-5.
11. Gjuric M, Gleeson M. Consensus statement and guidelines on the management of paragangliomas of the head and neck. Skull Base 2009;19:109-16.
12. Myssiorek D, Ferlito A, Silver CE, et al. Screening for familial paragangliomas. Oral Oncol 2008;44:532-7.
13. Cheung RL, Russell AC, Freeman J. Does routine preoperative imaging of parotid tumours affect surgical management decision making? J Otolaryngol Head Neck Surg 2008;37:430-4.
14. Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006;91:827-36.
15. Mhatre AN, Li Y, Feng L, et al. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas. Clin Genet 2004;66:461-6.
16. Hensen EF, Jordanova ES, van Minderhout IJ, et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 2004;23:4076-83.
17. Pasini B, Stratakis CA. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med 2009;266:19-42.
18. Semaan MT, Megerian CA. Current assessment and management of glomus tumors. Curr Opin Otolaryngol Head Neck Surg 2008;16:420-6.
19. Sanna M, Jain Y, De Donato G, et al. Management of jugular paragangliomas: the Gruppo Otologico experience. Otol Neurotol 2004;25:797-804. (Pubitemid 39223259)
20. McPherson GA, Halliday AW, Mansfield AO. Carotid body tumours and other cervical paragangliomas: diagnosis and management in 25 patients. Br J Surg 1989;76:33-6.
21. Patlola R, Ingraldi A, Walker C, et al. Carotid body tumor. Int J Cardiol 2009. DOI:10.1016/j.ijcard.2008.12.020.
22. Joynt KE, Moslehi JJ, Baughman KL. Paragangliomas: etiology, presentation, and management. Cardiol Rev 2009;17:159-64.
23. Erlic Z, Neumann HP. When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma? Clin Endocrinol (Oxf) 2009;70:354-7.